關於 spinraza ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. Spinraza Treatment for Spinal Muscular Atrophy (SMA) Patients

Spinraza (nusinersen) has been approved by the FDA and is now available for treatment of patients with SMA due to SMN1 mutations. The CUIMC - SMA Clinical ...

#12. FDA approves first drug for spinal muscular atrophy

FDA approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and ...

#13. [Pharmacological and clinical profile of spinal muscular ...

Nusinersen (Spinraza ® ) was approved as Japan's first antisense oligonucleotide (ASO) drug for treatment of SMA (spinal muscular atrophy) patients with a ...

#14. SPINRAZA Dosage & Rx Info | Uses, Side Effects - eMPR.com

Miscellaneous musculoskeletal disorders: Indications for: SPINRAZA. Spinal muscular atrophy (SMA). Adults and Children: Consider sedation ...

#15. Nusinersen (Spinraza) - Medical Clinical Policy Bulletins | Aetna

Spinraza is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. Nusinersen is available as Spinraza (Biogen, Inc.).

#16. Spinraza (nusinersen) dosing, indications, interactions ...

Medscape - Spinal muscular atrophy dosing for Spinraza (nusinersen), frequency-based adverse effects, comprehensive interactions, contraindications, ...

#17. Nusinersen (Spinraza) for Spinal Muscular Atrophy Treatment

... with spinal muscular atrophy is the FDA approval of a new medicine called nusinersen (brand name Spinraza) for the treatment of SMA in children and adults.

#18. Spinraza: Cost, alternatives, uses, how it works, and more

Spinraza is a brand-name prescription drug. It's FDA-approved to treat spinal muscular atrophy (SMA) in adults and children.

#19. Spinraza (PF) intrathecal: Uses, Side Effects ... - WebMD

How to use Spinraza (PF) 12 Mg/5 Ml Intrathecal Solution Spinal Muscular Atrophy Tx-Exon Inclusion Antisense Oligonuc. This medication is given by injection ...

#20. 全球首個治療脊髓性肌肉萎縮症藥物Spinraza獲美國FDA及歐盟 ...

Biogen 與Ionis製藥公司合作開發的Spinraza® (nusinersen) 於2016年9月4日通過U.S. FDA優先審查途徑，用於孩童與成人罕見遺傳性脊髓性肌肉萎縮症(簡稱SMA) 的治療， ...

#21. Spinraza | Muscular Dystrophy UK

Spinal muscular atrophy (SMA) is a devastating condition which, in the most severe cases, leaves babies with a life expectancy of rarely more than two years ...

#22. Home | SPINRAZA® (nusinersen) HCP

SPINRAZA ® is indicated for all patients with 5q‑associated SMA 1. The SPINRAZA® clinical trial programme included 346 patients aged from newborns to young ...

#23. Spinraza (nusinersen 12mg/5mL solution for injection) Drug ...

SPINRAZA comes as a clear and colourless solution in a glass vial. Each pack of SPINRAZA contains 12mg nusinersen in 5mL of solution in a single 5mL vial.

#24. Study Looks At Novel Administration of Spinraza - Managed ...

Spinraza is an antisense oligonucleotide that targets SMN2 gene and aims to increase production of the full-length survival motor neuron (SMN) ...

#25. Spinraza injection Uses, Side Effects & Warnings - Drugs.com

Spinraza is used to treat spinal muscular atrophy in adults, children, and infants. Spinraza may also be used for purposes not listed in this ...

#26. Spinraza | SMA Europe

Spinraza ™ is an antisense oligonucleotide designed to modify the product of the SMN2 “backup” gene to produce more functional SMN protein.

#27. Spinraza (nusinersen) for the Treatment of Spinal Muscular ...

Spinraza ™ (nusinersen) is an anti-sense oligonucleotide indicated for treatment of spinal muscular atrophy (SMA) in paediatric and adult patients.

#28. Side Effects of Spinraza Solution (Nusinersen), Warnings, Uses

Spinraza may interact with other drugs. Tell your doctor all medications and supplements you use. Spinraza During Pregnancy and Breastfeeding. Tell your doctor ...

#29. Spinraza (Nusinersen) Treatment for Spinal Muscular Atrophy

Spinraza is the brand name for nusinersen, a drug that is used for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

#30. Spinraza - TreatSMA

Spinraza ® is the trade name of a medication that contains an active substance called nusinersen, a chemical belonging to the class of antisense nucleotides ...

#31. Spinraza (nusinersen) - SMA News Today

Spinraza contains an antisense oligonucleotide that allows the body to produce more of a protein called survival motor neuron (SMN). SMN is ...

#32. Spinraza / Nusinersen - Spinal Muscular Atrophy UK

Marketed as SpinrazaTM, it was the first potentially disease-modifying treatment available in the UK for 5q SMA, which includes SMA Type 1, ...

#33. Spinraza® (Nusinersen) - UHCprovider.com

Spinraza ® (nusinersen) is proven and medically necessary for the treatment of spinal muscular atrophy (SMA) in patients.

#34. Spinraza™ / Minnesota Department of Human Services

Spinraza. Drug - Spinraza™ (nusinersen) [Biogen]. January 2020. Therapeutic area - Spinal Muscular Atrophy (SMA). Approval criteria.

#35. Biogen to study Spinraza in combination with $2 million ...

Biogen's Spinraza, the list price of which drops to $375,000 a year ... or if they could benefit from Spinraza treatment after gene therapy.

#36. initial experience in patients with sma type 1 treated in the ...

G299 Nusinersen (spinraza) is the first drug approved for spinal muscular atrophy (sma): ... Nusinersen (commercial name SPINRAZA) is a modified antisense ...

#37. 公告暫予支付Spinraza(主成分nusinersen)注射劑暨其藥品給付 ...

公告暫予支付Spinraza(主成分nusinersen)注射劑暨其藥品給付規定. 分類：健保署日期：2020-06-09. 衛生福利部中央健康保險署公告. 發布日期109.06.01.

#38. Citing 'less-than-optimal' outcomes for Roche's Evrysdi ...

Spinraza, also known as nusinersen, is already approved as a 12-mg dose, and the new trial will test loading doses of 50 mg two weeks apart plus ...

#39. Spinraza (nusinersen) | CenterWatch

Spinraza (nusinersen) is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide. Spinraza is specifically indicated for the treatment of spinal ...

#40. Argentina announces innovative reimbursement deal for ...

In this context, the reimbursement agreement for Spinraza serves as welcome news for Argentine SMA patients and their families, although ...

#41. New SPINRAZA® (nusinersen) Data Reinforce Sustained ...

New SPINRAZA® (nusinersen) Data Reinforce Sustained Efficacy and Longer-Term Safety Across Broad Range of Spinal Muscular Atrophy (SMA) Patients.

#42. reports of communicating hydrocephalus not related ... - GOV.UK

Spinraza is a medicine indicated for the treatment of 5q spinal muscular atrophy (SMA). Following an initial regimen of four loading doses over ...

#43. FDA Approves SPINRAZA - American College of Clinical ...

FDA Approves SPINRAZA (Nusinersen) for the Treatment of Spinal Muscular Atrophy in Pediatric and Adult Patients · On December 23, 2016, the US Food & Drug ...

#44. Spinraza in Adult Spinal Muscular Atrophy (SAS) - Clinical Trials

Assess effectiveness of SPINRAZA® (nusinersen) treatment on mobility and ambulation in ambulatory adult SMA patients, comparing changes in total distance walked ...

#45. Spinraza - NPS MedicineWise

SPINRAZA is a type of medicine called an anti-sense oligonucleotide (ASO). It is used to treat the genetic disease called Spinal Muscular Atrophy (SMA). Spinal ...

#46. Spinraza | Day Lab | Stanford Medicine

Spinraza Treatment for SMA at Stanford. Spinraza, is the first FDA-approved drug that increases SMN protein content in motor nerve cells; deficiency of SMN ...

#47. Nusinersen (Spinraza) for Spinal Muscular Atrophy

Nusinersen (Spinraza) is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

#48. Six Month Results of Spinraza in Adults with Spinal Muscular ...

Six Month Results of Spinraza in Adults with Spinal Muscular Atrophy (SAS) Study (2446). Craig M. Zaidman, Crystal M. Proud, ...

#49. Spinraza—a rare disease success story | Gene Therapy - Nature

This is precisely what Spinraza targets. Spinraza is a short string of synthetic genetic material directed to the product of the SMN2 gene, ...

#50. 22. Spinraza | FierceBiotech

Analysts didn't see Spinraza getting approval until mid-2017, but the FDA pulled through at the eleventh hour, making Biogen and Ionis the ...

#51. Spinraza launch set for blockbuster trajectory | BioPharma Dive

Biogen surprised the market Tuesday morning with much higher-than-expected earnings for its spinal muscular atrophy drug Spinraza (nusinersen).

#52. ICER Issues Final Report on Spinraza and Zolgensma ...

Spinraza was approved in 2016 for treatment of SMA in both children and adults. Zolgensma is a gene therapy that has been studied in infants with Type I SMA, ...

#53. Biogen's First Quarter Driven by MS Drugs and Spinraza

Spinraza, which was the first regulatory approved treatment in the United States for SMA, generated $364 million in global revenues.

#54. Nusinersen injection, for intrathecal use (Spinraza) HCPCS ...

Nusinersen injection, for intrathecal use (Spinraza) HCPCS code J2326 - Unclassified Drugs: Billing Guidelines and Change in Coverage.

#55. NHS England to fund first ever treatment for children with rare ...

Nusinersen, also called Spinraza and made by Biogen, is the first treatment that targets the underlying cause of spinal muscular atrophy ...

#56. HSE approves Spinraza after lengthy campaign by patients

The Health Service Executive has approved Spinraza, the only treatment on the market for the rare muscle-wasting disease spinal muscular ...

#57. Zolgensma Provides No Proven Benefit Over Spinraza In SMA ...

... compared with Biogen's Spinraza for treating spinal muscular atrophy, while Roche's Evrysdi offers a hint of benefit in one patient group.

#58. Positive outcome of joint reimbursement negotiations on ...

Belgium and the Netherlands have reached an agreement on the pricing of Spinraza, a drug for Spinal Muscular Atrophy (SMA). Spinraza will be ...

#59. Ontario grants broader access to SPINRAZA™ (nusinersen ...

SPINRAZA ™ (nusinersen) is the first and only approved treatment in Canada for spinal muscular atrophy (SMA). It is the only SMA therapy with a ...

#60. Zolgensma flatlines, but Spinraza isn't the beneficiary | Evaluate

Evrysdi is the latest headache to hit Spinraza, an antisense drug that until recently was the standard of care, and the gene therapy Zolgensma, ...

#61. hse-nusinersen-spinraza-protocol.pdf

Nusinersen (Spinraza®) for the treatment of Spinal Muscular Atrophy. Brand Name: Spinraza® 12 mg solution for injection. Formulation and Composition: Vial ...

#62. Biogen and Ionis Pharmaceuticals Announce SPINRAZA ...

Biogen and Ionis Pharmaceuticals Announce SPINRAZA (nusinersen) Meets Primary Endpoint at Interim Analysis of Phase 3 CHERISH Study in ...

#63. Spinraza «Biogen» - Felleskatalogen

Dosering. Behandling skal kun startes av lege med erfaring i behandling av spinal muskelatrofi (SMA). Beslutning om behandling skal baseres på individuell ...

#64. Biogen to launch study of higher Spinraza dose in patients ...

Biogen announced it intends to initiate a global phase 3b study to investigate clinical outcomes and safety of a higher dose of Spinraza in ...

#65. EU Approves Biogen's Spinraza - Drug Discovery and ...

The European Commission (EC) has granted a marketing authorization for SPINRAZA (nusinersen) for the treatment of 5q spinal muscular atrophy ...

#66. Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated ...

Biogen Inc's (NASDAQ: BIIB) Spinraza (nusinersen), spinal muscular atrophy (SMA) drug launched in early 2017, faces new competition from ...

#67. Spinraza® in type 0 SMA: a case study - Institut de Myologie

Treatment with Spinraza® (nusinersen) was started at the age of 13 days. After two months (after the third dose of treatment), the infant's ...

#68. Life-changing drug Spinraza still not covered for many ...

For several hundred Canadians with spinal muscular atrophy (SMA), Spinraza is a drug that means the difference between life and a slow, ...

#69. 脊瑞拉注射液的功效 - 康健知識庫

Spinraza Solution for injection，點擊看用法用量及副作用。適應症：經基因確診之SMA脊髓性肌肉萎縮症病人，其SMN2為2或3套或已出現症狀之SMA第一、二、三型病人， ...

#70. Spinraza (Nusinersen): Uses, Side Effects, Dosages ...

Spinraza is administered in a hospital, surgery center, or healthcare provider's office by a healthcare professional experienced in lumbar ...

#71. Nusinersen (Spinraza®) per 1 januari 2020 voorwaardelijk ...

Nusinersen is een weesgeneesmiddel dat is geregistreerd voor de behandeling van spinale musculaire atrofie (SMA), een zeldzame, erfelijke, ...

#72. SMA patients can switch from Spinraza to Zolgensma - Korea ...

A Korean pediatrician disclosed the first data of local patients with spinal muscular atrophy (SMA) treated with Novartis' gene therapy ...

#73. Biogen plans trial of Spinraza in patients not responding to ...

Biogen is planning to trial its Spinraza spinal muscular atrophy (SMA) drug in patients who have not responded properly to Novartis gene ...

#74. The new price of hope - The Boston Globe

Spinraza, a newly approved drug for spinal muscular atrophy has faced slow ramp-ups at hospitals and resistance by health insurers spooked by ...

#75. Biogen reports new data backing long-term benefit of Spinraza

Biogen has revealed new data for its spinal muscular atrophy (SMA) treatment Spinraza, showing long-term benefit and new insights into the ...

#76. Spinraza nusinersen Molina Clinical Policy 293

This policy addresses the coverage of Spinraza (nusinersen) for the treatment of spinal muscular atrophy (SMA). The.

#77. Spinraza® (nusinersen) injection, for intrathecal use - Accredo

Date. Time ______ Date medication needed. Prescriber's name and title. If NP or PA, under direction of Dr. Office contact and title ...

#78. Nusinersen (Spinraza™) for spinal muscular atrophy (SMA)

On December 23, 2016, the U.S. Food and Drug Administration (FDA) approved the use of nusinersen (brand name: Spinraza), a new drug treatment for spinal ...

#79. SPINRAZA (nusinersen) - Haute Autorité de Santé

SPINRAZA est un traitement de première intention chez les nourrissons et enfants pré-symptomatiques ayant une amyotrophie spinale ...

#80. Spinraza CRD Prior Authorization Form - Cigna

Spinraza. (nusinersen). PHYSICIAN INFORMATION. PATIENT INFORMATION. * Physician Name: *Due to privacy regulations we will not be able to respond via fax.

#81. Spinal Muscular Atrophy Agents – nusinersen (Spinraza)

Policy: Spinraza®. Medical Policy No. 74.70.00-2. Last Updated 04/01/2021. 1. Spinal Muscular Atrophy Agents – nusinersen. (Spinraza).

#82. Spinraza® (Nusinersen) Criteria - New Hampshire ...

Spinraza ® (nusinersen) Criteria. Approval Date: August 7, 2020. Criteria for Approval. 1. Patient must have documentation of a confirmed diagnosis of spinal ...

#83. Spinraza: Bristol teenager 'ineligible' for SMA drug - BBC News

Jake Ogborne has spinal muscular atrophy and his health is worsening but he cannot be given Spinraza.

#84. Spinraza - Prescription Prices and Coupons from GoodRx

Compare prices and print coupons for Spinraza and other Musculoskeletal Conditions Drugs at CVS, Walgreens, and other pharmacies.

#85. Life-saving Spinal Muscular Atrophy medicine to be made ...

The expanded listing of Spinraza will allow infants and children, diagnosed with SMA through a genetic test, to start treatment prior to the ...

#86. New Results From Landmark NURTURE Study Show That

After up to 4.8 years of continuous treatment with SPINRAZA, 100 percent of children treated pre-symptomatically were alive, ...

#87. BC increasing access to spinal muscular atrophy treatment

Coverage for Spinraza (nusinersen), a new medication, will no longer be limited to Type 1 patients. In keeping with the most recent ...

#88. Spinraza (Nusinersen (Injection)) - Side Effects, Interactions ...

Find everything you need to know about Spinraza (Nusinersen (Injection)), including what it is used for, warnings, reviews, side effects, ...

#89. Spinraza access agreement extended | News and features

Spinraza access agreement extended. More children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with Spinraza ...

#90. Spinraza (nusinersen) - Wellmark

Spinraza is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. POLICY. Required Documentation.

#91. Nusinersin (Spinraza®) | National Centre for ...

Pharmacoeconomic Evaluation of Nusinersin (Spinraza®) for the treatment of 5q spinal muscular atrophy (SMA)

#92. Response to Comments: Nusinersen (Spinraza) - CMS

The following are the comment summaries and contractor responses for Novitas Solutions Draft Local Coverage Determination (LCD) DL37682 Nusinersen (Spinraza) ...

#93. NICE expands access for SMA drug Spinraza - PharmaTimes

Initially, NICE recommended funding for Spinraza (nusinersen) through the MAA scheme to enable patients to access the drug while more ...

#94. Tag: Spinraza - Muscular Dystrophy Canada

Alberta fourth province to expand access to SPINRAZA™ for patients impacted with Spinal Muscular Atrophy. Muscular Dystrophy Canada (MDC) commends the ...

#95. Spinraza_Criteria.pdf - AHCA

SPINRAZA ® (nusinersen). LENGTH OF AUTHORIZATION: 5 doses/8 months. REVIEW CRITERIA: • Confirmed diagnosis of spinal muscular atrophy (SMA) ...

#96. Breakthrough Prize goes to researchers behind Biogen's ...

Spinraza is a first-of-its-kind treatment that targets the gene responsible for producing a protein called SMN, which is key to motor ...